CO.DON AG INH. O.N.
co.don AG does not have significant operations. Previously, the company was engaged in the development, production, and marketing of biopharmaceutical products for joint preservation and the regenerative treatment of articular cartilage defects worldwide. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.
Market Cap & Net Worth: CO.DON AG INH. O.N. (CNW)
CO.DON AG INH. O.N. (F:CNW) has a market capitalization of $411.46K (€400.85K) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #37974 globally and #5019 in its home market, demonstrating a 25.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CO.DON AG INH. O.N.'s stock price €0.02 by its total outstanding shares 26723358 (26.72 Million).
CO.DON AG INH. O.N. Market Cap History: 2015 to 2026
CO.DON AG INH. O.N.'s market capitalization history from 2015 to 2026. Data shows change from $140.05 Million to $411.46K (-42.09% CAGR).
CO.DON AG INH. O.N. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CO.DON AG INH. O.N.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CNW by Market Capitalization
Companies near CO.DON AG INH. O.N. in the global market cap rankings as of March 18, 2026.
Key companies related to CO.DON AG INH. O.N. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
CO.DON AG INH. O.N. Historical Marketcap From 2015 to 2026
Between 2015 and today, CO.DON AG INH. O.N.'s market cap moved from $140.05 Million to $ 411.46K, with a yearly change of -42.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €411.46K | +36.36% |
| 2025 | €301.74K | +46.67% |
| 2024 | €205.73K | -30.56% |
| 2023 | €296.25K | -60.00% |
| 2022 | €740.63K | -98.26% |
| 2021 | €42.52 Million | -37.50% |
| 2020 | €68.03 Million | -32.97% |
| 2019 | €101.49 Million | -38.99% |
| 2018 | €166.35 Million | -53.99% |
| 2017 | €361.53 Million | +148.93% |
| 2016 | €145.23 Million | +3.70% |
| 2015 | €140.05 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of CO.DON AG INH. O.N. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $411.46K USD |
| MoneyControl | $411.46K USD |
| MarketWatch | $411.46K USD |
| marketcap.company | $411.46K USD |
| Reuters | $411.46K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.